Skip to main content
Log in

Serotonin and the Vascular System

Role in Health and Disease, and Implications for Therapy

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Serotonin released from aggregating platelets can reach sufficient concentrations to affect local vascular function in a number of ways. The monoamine can cause contraction of blood vessels by its direct action on smooth muscle or by potentiating the effect of other vasoconstrictor agents. It can also induce vasodilatation by a direct relaxing effect on smooth muscle, by inhibition of adrenergic nerves, and by release of an uncharacterised relaxing factor from endothelial cells. One of its most likely physiological roles is to aid in haemostasis by promoting platelet aggregation and by causing local vasoconstriction at sites of injury. It probably has a role in some forms of vascular pathology as well: it may contribute to vasospasm of cerebral, coronary, and digital arteries, particularly if there is endothelial dysfunction or damage.

Much evidence has implicated serotonin (5-hydroxytryptamine) in the pathogenesis of migraine. Serotonergic agonists, such as ergotamine, and antagonists, such as methys-ergide and pizotifen, are both used in therapy of migraine. Promising but conflicting early results have not yet defined a place for serotonergic antagonists in other vasospastic disorders. The antihypertensive efficacy of one serotonergic antagonist, ketanserin, raises questions about the possible involvement of serotonin in either the initiation or the maintenance of the elevated peripheral vascular resistance in several forms of hypertension, including essential hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahlman H, Bhargava HN, Donahue PE, Newson B, Das Gupta TK, et al. The vagal release of 5-hydroxytryptamine from enterochromaffin cells in the cat. Acta Physiologica Scandinavica 104: 262–270, 1978

    PubMed  CAS  Google Scholar 

  • Allen GS, Gold LHA, Chou SN, French LA. Cerebral arterial spasm. Part 3: In vivo intracisternal production of spasm by serotonin and blood and its reversal by phenoxybenzamine. Journal of Neurosurgery 40: 451–458, 1974c

    PubMed  CAS  Google Scholar 

  • Allen GS, Gross CJ, French LA, Chou SN. Cerebral arterial spasm. Part 5: In vitro contractile activity of vasoactive agents including human CSF on human basilar and anterior cerebral arteries. Journal of Neurosurgery 44: 594–600, 1976

    PubMed  CAS  Google Scholar 

  • Allen GS, Henderson LM, Chou SN, French LA. Cerebral arterial spasm. Part I: in vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. Journal of Neurosurgery 40: 433–441, 1974a

    PubMed  CAS  Google Scholar 

  • Allen GS, Henderson LM, Chou SN, French LA. Cerebral arterial spasm. Part 2: In vitro contractile activity of serotonin in human serum and CSF on the canine basilar artery, and its blockage by methylsergide and phenoxybenzamine. Journal of Neurosurgery 40: 442–450, 1974b

    PubMed  CAS  Google Scholar 

  • Amery A, Fagard R, Fiocchi R, Lijnen P, Staessen J, et al. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients. Journal of Cardiovascular Pharmacology 6: 182–185, 1984

    PubMed  CAS  Google Scholar 

  • Andren L, Svensson A, Dahlof B, Eggertsen R, Hansson L. Ketanserin in hypertension. Acta Medica Scandinavica 214: 125–130, 1983

    PubMed  CAS  Google Scholar 

  • Anthony M, Hinterberger H, Lance JW. Plasma serotonin in migraine and stress. Archives of Neurology 16: 544–552, 1967

    PubMed  CAS  Google Scholar 

  • Astrom A, Samelius U. The action of 5-hydroxytryptamine and some of its antagonists on the umbilical vessels of the human placenta. British Journal of Pharmacology 12: 410–414, 1957

    CAS  Google Scholar 

  • Beale G, Bogaerts H, Clement DL, Pannier R, Barbier F. Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease. Thrombosis Research 23: 215–223, 1981

    Google Scholar 

  • Boullin DJ. Recent advances in vasospasm research. In Boullin DJ (Ed.) Cerebral Vasospasm, pp. 293–299, John Wiley and Sons, Chichester, 1980

    Google Scholar 

  • Boullin DJ, Mohan J, Grahame-Smith DG. Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid haemorrhage. Journal of Neurology, Neurosurgery and Psychiatry 39: 756–766, 1976

    CAS  Google Scholar 

  • Bove AA, Dewey JD. Effects of serotonin and histamine on proximal and distal coronary vasculature in dogs: comparison with alpha-adrenergic stimulation. American Journal of Cardiology 52: 1333–1339, 1983

    PubMed  CAS  Google Scholar 

  • Brazenor RM, Angus JA. Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors. Journal of Pharmacology and Experimental Therapeutics 218: 530–536, 1981

    PubMed  CAS  Google Scholar 

  • Brazenor RM, Angus JA. Actions of serotonin antagonists on dog coronary artery. European Journal of Pharmacology 81: 569–576, 1982

    PubMed  CAS  Google Scholar 

  • Brown H. Serotonin-producing tumors. In Essman (Ed.) Serotonin in Health and Disease, pp. 393–423, Spectrum, New York, 1977

    Google Scholar 

  • Buccino RA, Covell JA, Sonnenblick EH, Braunwald E. Effects of serotonin on the contractile state of the myocardium. American Journal of Physiology 213: 483–486, 1967

    PubMed  CAS  Google Scholar 

  • Burks TF, Long JP. 5-Hydroxytryptamine release into dog intestinal vasculature. American Journal of Physiology 211: 619–625, 1966

    PubMed  CAS  Google Scholar 

  • Chahine RA, Raizner AE, Luchi RJ. Coronary arterial spasm in classic angina pectoris. Catheterization and Cardiovascular Diagnosis 1: 337–342, 1975

    PubMed  CAS  Google Scholar 

  • Chand N, Altura BM. Serotonin receptors subserve only contraction in canine and rat pulmonary arteries and veins. Artery 7: 232–245, 1980

    PubMed  CAS  Google Scholar 

  • Cocks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305: 627–630, 1983

    PubMed  CAS  Google Scholar 

  • Cohen ML, Fuller RW, Kurz KD. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats. Hypertension 5: 676–681, 1983

    PubMed  CAS  Google Scholar 

  • Cohen RA, Coffman JD. Digital vasospasm: the pathophysiology of Raynaud’s phenomenon. International Angiology 3: 47–55, 1984

    Google Scholar 

  • Cohen RA, Shepherd JT, Vanhoutte PM. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 221: 273–274, 1983a

    PubMed  CAS  Google Scholar 

  • Cohen RA, Shepherd JT, Vanhoutte PM. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. American Journal of Physiology 245: H1077–H1080, 1983b

    PubMed  CAS  Google Scholar 

  • Collis MG, Vanhoutte PM. Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats. Circulation Research 41: 759–767, 1977

    PubMed  CAS  Google Scholar 

  • Cortellaro M, Boschetti C, Antoniazzi V, Moreo G, Repetto S, et al. Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis — effect of sulphinpyrazone treatment. Thrombosis and Haemostasis 50: 857–859, 1983

    PubMed  CAS  Google Scholar 

  • Crawford NV. Systemic venous platelet-bound and plasma free serotonin levels in non-carcinoid malignancy. Clinica Chimica Acta 12: 274–281, 1965

    CAS  Google Scholar 

  • Curro FA, Greenberg S, Verbeuren TJ, Vanhoutte PM. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins. Journal of Pharmacology and Experimental Therapeutics 207: 936–949, 1978

    PubMed  CAS  Google Scholar 

  • Curry RC, Pepine CJ, Sabom MB, Conti CR. Similarities of ergonovine-induced and spontaneous attacks of variant angina. Circulation 59: 307–312, 1979

    PubMed  Google Scholar 

  • De Clerck F, Van Nueten JM. Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin. Thrombosis Research 27: 713–727, 1982

    PubMed  Google Scholar 

  • De Clerck F, David J-L, Janssen PAJ. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R41468), a selective 5-HT2-receptor antagonist. Agents and Actions 12: 388–397, 1982

    PubMed  Google Scholar 

  • De Cree J, Leempoels J, Geukens H, De Cock W, Verhaegen H. The antihypertensive effects of ketanserin (R41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension. Clinical Science 61: 473s–476s, 1981a

    PubMed  Google Scholar 

  • De Cree J, Leempoels J, De Cock W, Geukens H, Verhaegen H. The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R41468) in elderly patients. Angiology 32: 137–144, 1981b

    PubMed  Google Scholar 

  • De La Lande IS, Cannell VA, Waterson JC. The interaction of serotonin and noradrenaline on the perfused artery. British Journal of Pharmacology 28: 255–272, 1966

    Google Scholar 

  • De Mey C, Vanhoutte PM. Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney. Hypertension 3: 718–724, 1981

    PubMed  Google Scholar 

  • De Roose J, Symoens J. Ketanserin in acute superficial thrombophlebitis. Lancet 2: 440–441, 1982

    PubMed  Google Scholar 

  • Degli Uberti EC, Trasforini G, Margutti AR, Rotola CA, Pansini R. Effect of ketanserin, a new inhibitor of 5-HT2 receptors, on plasma renin activity and aldosterone levels in normal subjects. Hormone Research 16: 244–248, 1982

    PubMed  CAS  Google Scholar 

  • Edvinsson L, Hardebo JE, Owman C. Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circulation Research 42: 143–151, 1978

    PubMed  CAS  Google Scholar 

  • Edvinsson L, Degueurce A, Duverger D, MacKenzie ET, Scatton B. Central serotonergic nerves project to the pial vessels of the brain. Nature 306: 55–57, 1983

    PubMed  CAS  Google Scholar 

  • Engbaek F, Voldby B. Radioimmunoassay of serotonin (5-hydroxytryptamine) in cerebrospinal fluid, plasma, and serum. Clinical Chemistry 28: 624–628, 1982

    PubMed  CAS  Google Scholar 

  • Engel G, Gothert M, Muller-Schweinitzer E, Schlicker E, Sistonen L, et al. Evidence for common pharmacological properties of 3H-5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Nau-nyn-Schmiedeberg’s Archives of Pharmacology 324: 116–124, 1983

    CAS  Google Scholar 

  • Epstein S, Hamilton S. Cyproheptadine inhibition of stimulated plasma renin activity. Journal of Clinical Endocrinology and Metabolism 45: 1235–1237, 1977

    PubMed  CAS  Google Scholar 

  • Erspamer V. Recent research in the field of 5-hydroxytryptamine and related indolealkylamines. In Jucker E (Ed.) Progress in Drug Research, pp. 151–331, Interscience Publishers, New York, 1961

    Google Scholar 

  • Erspamer V, Asero B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169: 800–801, 1952

    PubMed  CAS  Google Scholar 

  • Fagard R, Cattaert A, Lijnen P, Staessen J, Vanhees L, et al. Responses of the systemic circulation and of the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man. Clinical Science 66: 17–25, 1984

    PubMed  CAS  Google Scholar 

  • Fanchamps A. The evolution of thinking about the role and site of action of serotonin in migraine. In Critchley (Ed.) Advances in Neurology, Vol. 33. Headache: physiopathological and clinical concepts, pp. 31–33, Raven Press, New York, 1982

    Google Scholar 

  • Feniuk W, Humphrey PPA, Watts AD. Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. British Journal of Pharmacology 67: 247–254, 1979

    PubMed  CAS  Google Scholar 

  • Feniuk W, Humphrey PPA, Watts AD. 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. European Journal of Pharmacology 96: 71–78, 1983

    PubMed  CAS  Google Scholar 

  • Fillion GMB, Iluch S, Uvnas B. Release of noradrenaline from the dog heart in situ after intravenous and intracoronary administration of 5-hydroxytryptamine. Acta Physiologica Scandinavica 83: 115–123, 1971

    PubMed  CAS  Google Scholar 

  • Finch L. Vascular reactivity in hypertensive rats after treatment with antihypertensive agents. Life Sciences 15: 1827–1836, 1974

    PubMed  CAS  Google Scholar 

  • Fozard JR. Mechanism of the hypotensive effect of ketanserin. Journal of Cardiovascular Pharmacology 4: 829, 1982a

    PubMed  CAS  Google Scholar 

  • Fozard JR. Basic mechanisms of antimigraine drugs. In Critchley et al. (Eds) Advances in Neurology, Vol. 33. Headache: physiopathological and clinical concepts, pp. 295–307, Raven Press, New York, 1982b

    Google Scholar 

  • Fozard JR. 5-Hydroxytryptamine in the pathophysiology of migraine. In Bevan et al. (Eds) Vascular neuroeffector mechanisms V, pp. 321–328 Elserier, Amsterdam, 1985

    Google Scholar 

  • Freedman SB, Chierchia S, Rodriguez-Plaza L, Bugiardini R, Smith G, et al. Ergonovine-induced myocardial ischemia: no role for serotonergic receptors? Circulation 70: 178–183, 1984

    PubMed  CAS  Google Scholar 

  • Freeman WK, Rorie DK, Tyce GM. Effects of 5-hydroxytryptamine on neuroeffector junction in human pulmonary artery. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 51: 693–698, 1981

    CAS  Google Scholar 

  • Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circulation Research 53: 556–573, 1983

    Google Scholar 

  • Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Annual Review of Pharmacology and Toxicology 24: 175–197, 1984

    PubMed  CAS  Google Scholar 

  • Gaddum JH. Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine. Journal of Physiology (London) 121: 15P, 1953

    CAS  Google Scholar 

  • Gaddum JH, Picarelli ZP. Two kinds of tryptamine receptor. British Journal of Pharmacology 12: 323–328, 1957

    CAS  Google Scholar 

  • Genefke IK, Garel A, Mandel P. Factors influencing free serotonin in human plasma. Clinica Chimica Acta 20: 61–67, 1968

    CAS  Google Scholar 

  • Graham JR. Cardiac and pulmonary fibrosis during methysergide therapy for headache. American Journal of the Medical Sciences 254: 1, 1967

    PubMed  CAS  Google Scholar 

  • Griffith SG, Lincoln J, Burnstock G. Serotonin as a neurotransmitter in cerebral arteries. Brain Research 247: 388, 1982

    PubMed  CAS  Google Scholar 

  • Gross MD, Grekin RJ, Gniadek TC, Villareal JZ. Suppression of aldosterone by cyproheptadine in idiopathic aldosternoism. New England Journal of Medicine 305: 181–185, 1981

    PubMed  CAS  Google Scholar 

  • Haeusler G, Finch L. Vascular reactivity to 5-hydroxytryptamine and hypertension in the rat. Naunyn-Schmiedeberg’s Archives of Pharmacology 272: 101–116, 1972

    PubMed  CAS  Google Scholar 

  • Halpern A, Kuhn PH, Shaftel HE, Samuels SS, Shaftel N, et al. Raynaud’s disease, Raynaud’s phenomenon, and serotonin. Angiology 11: 151–167, 1960

    PubMed  CAS  Google Scholar 

  • Hedner T, Persson B, Berglund G. Experience with ketanserin, a serotonin (S2) antagonist, in longterm treatment of essential hypertension. Clinical and Experimental Hypertension, Part A: Theory and Practice A6: 743–751, 1984

    Google Scholar 

  • Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercho-lesterolemic and atherosclerotic monkeys. Circulation Research 54: 711–718, 1984

    PubMed  CAS  Google Scholar 

  • Henry PD, Yokoyama M. Supersensitivity of atherosclerotic rabbit aorta to ergonovine: mediation by a serotonergic mechanism. Journal of Clinical Investigation 66: 306–313, 1980

    PubMed  CAS  Google Scholar 

  • Holmsen H. Biochemistry of the platelet release reaction. Ciba Symposia, 35: 175–205, 1975

    CAS  Google Scholar 

  • Holtz J, Held W, Sommer O, Kuhne G, Bassenge E. Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: alpha-adrenoceptors are not involved. Basic Research in Cardiology 77: 278–291, 1982

    PubMed  CAS  Google Scholar 

  • Houston DS, Shepherd JT, Vanhoutte PM. Adenine nucleotides, serotinin and endothelium-dependent relaxations to platelets. American Journal of Physiology 248: H389–H395, 1985

    PubMed  CAS  Google Scholar 

  • Hutton RA, Mikhailidis DP, Bernstein RM, Jeremy JY, Hughes GRV, et al. Assessment of platelet function in patients with Raynaud’s syndrome. Journal of Clinical Pathology 37: 182–187, 1984

    PubMed  CAS  Google Scholar 

  • Huval WV, Lelcuk S, Shepro D, Hechtman HB. Role of serotonin in patients with acute respiratory failure. Annals of Surgery 200: 166–172, 1984

    PubMed  CAS  Google Scholar 

  • Huval WV, Mathieson MA, Stemp LI, Dunham BM, Jones AG, et al. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism. Annals of Surgery 197: 220–225, 1983

    PubMed  CAS  Google Scholar 

  • Imaizumi Y, Baba M, Imaizumi Y, Watanabe M. Involvement of endothelium in the relaxation of isolated chick jugular vein by 5-hydroxytryptamine. European Journal of Pharmacology 97: 335–336, 1984

    PubMed  CAS  Google Scholar 

  • Jauernig RA, Moulds RFW. A human arterial preparation for studying the effects of vasoactive agents. Circulation Research 42: 363–368, 1978

    PubMed  CAS  Google Scholar 

  • Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science 223: 1435–1437, 1984

    PubMed  CAS  Google Scholar 

  • Kawachi Y, Tomoike H, Maruoka Y, Kikuchi Y, Araki H, et al. Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis. Circulation 69: 441–450, 1984

    PubMed  CAS  Google Scholar 

  • Krupp P, Krupp I. Serotonin and toxemia of pregnancy. Obstetrics and Gynecology 15: 237–241, 1960

    PubMed  CAS  Google Scholar 

  • Kuhn DM, Wolf WA, Lovenberg W. Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension 2: 243–255, 1980

    PubMed  CAS  Google Scholar 

  • Larsson I, Ahlman H, Bhargava HN, Dahlstrom A, Petterson G, et al. The effects of splanchnic nerve stimulation on the plasma levels of serotonin and substance P in the portal vein of the cat. Journal of Neural Transmission 46: 105–112, 1979

    CAS  Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, et al. Receptor binding profile of R41468, a novel antagonist at 5-HT2 receptors. Life Sciences 28: 1015–1022, 1981

    PubMed  CAS  Google Scholar 

  • Lindblad LE, Shepherd JT, Vanhoutte PM. Cooling augments platelet-induced contraction of peripheral arteries of the dog. Proceedings of the Society for Experimental Biology and Medicine 176: 119–122, 1984

    PubMed  CAS  Google Scholar 

  • Lingjaerde O. Platelet uptake and storage of serotonin. In Essman WB (Ed.) Serotonin in health and disease, pp. 139–199, Spectrum, New York, 1977

    Google Scholar 

  • Luchi RJ, Chahine RA, Raizner AD. Coronary artery spasm. Annals of Internal Medicine 91: 441–449, 1979

    PubMed  CAS  Google Scholar 

  • Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. Journal of Clinical Investigation 66: 979–986, 1980.

    PubMed  CAS  Google Scholar 

  • Marwood JF, Stokes GS. Studies on the mechanism of action of the hypotensive effect of ketanserin. Clinical and Experimental Pharmacology and Physiology 11: 125–132, 1984

    PubMed  CAS  Google Scholar 

  • Maseri A, Pesola A, Marzilli M, Severi S, Parodi O, et al. Coronary vasospasm in angina pectoris. Lancet 1: 713–717, 1977

    PubMed  CAS  Google Scholar 

  • McCall RB, Schuette MR. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin. Journal of Pharmacology and Experimental Therapeutics 228: 704–710, 1984

    PubMed  CAS  Google Scholar 

  • McGoon MD, Vanhoutte PM. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. Journal of Clinical Investigation 74: 828–833, 1984

    PubMed  CAS  Google Scholar 

  • McGrath MA. 5-Hydroxytryptamine and neurotransmitter release in canine blood vessels: inhibition by low and augmentation by high concentrations. Circulation Research 41: 428–435, 1977

    PubMed  CAS  Google Scholar 

  • Mehta J, Mehta P. Platelet function in hypertension and effect of therapy. American Journal of Cardiology 47: 331–334, 1981

    PubMed  CAS  Google Scholar 

  • Meuleman TR, Hill DC, Port JD, Stanley TH, Pace NL, et al. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction. Critical Care Medicine 11: 606–611, 1983

    PubMed  CAS  Google Scholar 

  • Mohan J. The neurosurgeon’s view. In Boullin (Ed.) Cerebral vasospasm, pp. 15–35, John Wiley and Sons, Chichester, 1980

    Google Scholar 

  • Moulds RFW, Iwanov V, Medcalf RL. The effects of platelet-derived contractile agents on human digital arteries. Clinical Science 66: 443–451, 1984

    PubMed  CAS  Google Scholar 

  • Muller-Schweinitzer E, Engel G. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Naunyn-Schmiedeberg’s Archives of Pharmacology 324: 287–292, 1983

    PubMed  CAS  Google Scholar 

  • Nagai H, Noda S, Mabe H. Experimental cerebral vasospasm. Part 2: Effects of vasoactive drugs and sympathectomy on early and late spasm. Journal of Neurosurgery 42: 420–428, 1975

    PubMed  CAS  Google Scholar 

  • Nevelsteen A, De Clerck F, Loots W, De Gryse A. Restoration of post-thrombotic peripheral collateral circulation in the cat by ketanserin, a selective 5-HT2-receptor antagonist. Interntional Archives of Pharmacodynamics and Therapy 270: 268–279, 1984

    CAS  Google Scholar 

  • Nielson SL, Vitting K, Rasmussen K. Prazosin treatment of primary Raynaud’s phenomenon. European Journal of Clinical Pharmacology 24: 421–423, 1983

    Google Scholar 

  • Ohta T, Osaka K, Siguma M, Yamamoto M, Shimizu K, et al. Cerbral vasospasm following ruptured intracranial aneurysms, especially some contributions of potassium ion released from subarachnoid hematoma to delayed cerebral vasospasm. In Bevan SA et al. (Eds) Vascular neuroeffector mechanisms, 4th International Symposium, pp. 353–358, Raven Press, New York, 1983

    Google Scholar 

  • Ojemann RG, Crowell RM. Surgical management of cerebrovascular disease, pp. 128–140, Williams and Wilkins, Baltimore, 1983

    Google Scholar 

  • Page IH. Serotonin (5-hydroxytryptamine). Physiological Reviews 34: 563–588, 1954

    PubMed  CAS  Google Scholar 

  • Page IH, McCubbin JW. The variable arterial pressure response to serotonin in laboratory animals and man. Circulation Research 1: 354–362, 1953

    PubMed  CAS  Google Scholar 

  • Peroutka SJ, Snyder SH. Multiple serotonin receptors: differential binding of 3H-5-hydroxytryptamine, 3H-lysergic acid diethylamide and 3H-spiroperidol. Molecular Pharmacology 16: 687–699, 1979

    PubMed  CAS  Google Scholar 

  • Peroutka SJ, Noguchi M, Tolner DJ, Allen GS. Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors. Brain Research 259: 327–330, 1983

    PubMed  CAS  Google Scholar 

  • Rapport MM. Serum vasoconstrictor (Serotonin) V: presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle. Journal of Biology and Chemistry 180: 961–969, 1949

    CAS  Google Scholar 

  • Raskin NH. Pharmacology of migraine. Annual Review of Pharmacology and Toxicology 21: 463–478, 1981

    PubMed  CAS  Google Scholar 

  • Reinhard JF, Liebmann JE, Schlosberg AJ. Serotonin neurons project to small blood vessels in the brain. Science 206: 85–87, 1979

    PubMed  CAS  Google Scholar 

  • Roddie IC, Shepherd JT, Whelan RF. The action of 5-hydroxytryptamine on the blood vessels of the human hand and forearm. British Journal of Pharmacology 10: 445–450, 1955

    CAS  Google Scholar 

  • Rydzewski W. Serotonin (5-HT) in migraine:levels in whole blood in and between attacks. Headache 16: 16–19, 1976

    PubMed  CAS  Google Scholar 

  • Salmon S, Bonciani M, Fanciullacci M, Marianelli L, Michelacci S, et al. A putative 5-HT central feedback in migraine and cluster headache attacks. In Critchley et al. (Eds) Advances in neurology, Vol. 33. Headache: physiopathological and clinical concepts, pp. 265–274, Raven Press, New York, 1982

    Google Scholar 

  • Saper JR. Migraine: I. Classification and pathogenesis. Journal of the American Medical Association 239: 2380–2383, 1978

    PubMed  CAS  Google Scholar 

  • Sasaki T, Wakai S, Asano T, Takakura K, Sano K. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581. Journal of Neurosurgery 57: 74–82, 1982

    PubMed  CAS  Google Scholar 

  • Saxena PR. Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. European Journal of Pharmacology 27: 99–105, 1974

    PubMed  CAS  Google Scholar 

  • Schaub RG, Meyers KM, Sande RD. Serotonin as a factor in depression of collateral blood flow following experimental arterial thrombosis. Journal of Laboratory and Clinical Medicine 90: 645–653, 1977

    PubMed  CAS  Google Scholar 

  • Schroeder JS, Bolen JL, Quint RA, Clark DA, Hayden WG, et al. Provocation of coronary spasm with ergonovine maleate. American Journal of Cardiology 40: 487–491, 1977

    PubMed  CAS  Google Scholar 

  • Seibold JR, Jageneau AHM. Treatment of Raynaud’s phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor. Arthritis and Rheumatism 27: 139–146, 1984

    PubMed  CAS  Google Scholar 

  • Senior JB, Fahim I, Sullivan FM, Robson JM. Possible role of 5-hydroxytryptamine in toxaemia of pregnancy. Lancet 2: 553–554, 1963

    PubMed  CAS  Google Scholar 

  • Shafer AI, Crawford DD, Gimbrone MA. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. Journal of Clinical Investigation 73: 1105–1112, 1984

    Google Scholar 

  • Sibbald W, Peters S, Lindsay RM. Serotonin and pulmonary hypertension in human septic ARDS. Critical Care Medicine 8: 490–494, 1980

    PubMed  CAS  Google Scholar 

  • Sicuteri F, Testi A, Anselmi B. Biochemical investigations in headache: increase in the hydroxyindoleacetic acid excretion during migraine attacks. International Archives of Allergy 19: 55–58, 1961

    CAS  Google Scholar 

  • Sjaastad O. The significance of blood serotonin levels in migraine: a critical review. Acta Neurologica Scandinavica 51: 200–210, 1975.

    PubMed  CAS  Google Scholar 

  • Somerville BW. Platelet-bound and free serotonin levels in jugular and forearm venous blood during migraine. Neurology 26: 41–45, 1976

    PubMed  CAS  Google Scholar 

  • Spatz M. Serotonin in cardiac disease. In Essman WB (Ed.) Serotonin in Health and Disease, Vol. V, Clinical applications, pp. 389–401, Spectrum, New York, 1979

    Google Scholar 

  • Speight TM, Avery GS. Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 3: 159–203, 1972

    PubMed  CAS  Google Scholar 

  • Stranden E, Roald OK, Krohg K. Treatment of Raynaud’s phenomenon with the 5-HT2-receptor antagonist ketanserin. British Medical Journal 285: 1069–1071, 1982

    PubMed  CAS  Google Scholar 

  • Strum JM, Junod AF. Radioautographic demonstration of 5-hydroxytryptamine-3H uptake by pulmonary endothelial cells. Journal of Cell Biology 54: 456–467, 1972

    PubMed  CAS  Google Scholar 

  • Tada M, Kuzuya T, Inoue M, Kodama K, Mishima M, et al. Elevation of thromboxane B2 levels in patients with classic and variant angina pectoris. Circulation 64: 1107–1115, 1981

    PubMed  CAS  Google Scholar 

  • Tell GP, Fozard JR, Schechter PJ, Centonze V, Beorchia S, Loisy C. Controlled study of MDL 72222, an antagonist at neuronal 5-HT receptors, in the symptomatic treatment of migraine. British Journal of Pharmacology, abstract, in press, 1984

    Google Scholar 

  • Thompson JH. Serotonin and the alimentary tract. Research Communications in Chemical Pathology and Pharmacology 2: 687–782, 1971

    PubMed  CAS  Google Scholar 

  • Thompson JH. Serotonin (5-hydroxytryptamine) and the alimentary system. In Essman (Ed.) Serotonin in Health and Disease, Vol. 4, pp. 201–392, Spectrum, New York, 1977

    Google Scholar 

  • Todd MH, Forrest JB, Cragg DBJ. The effects of aspirin and methysergide on responses to clot-induced pulmonary embolism. American Heart Journal 105: 769–776, 1983

    PubMed  CAS  Google Scholar 

  • Turpie AGG, de Boer AC, Genten E. Platelet consumption in cardiovascular disease. Seminars in Thrombosis and Hemostasis 8: 161–185, 1982

    PubMed  CAS  Google Scholar 

  • Utsunomiya T, Krausz MM, Shepro D, Hechtman HB. Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals. American Journal of Physiology 241: H766–H771, 1981

    PubMed  CAS  Google Scholar 

  • Van der Starre PJA, Scheijgrond HW, Reneman RS, Rolling JB. The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery. Anesthesia and Analgesia 62: 63–69, 1983

    PubMed  Google Scholar 

  • Vanhoutte PM. 5-Hydroxytryptamine, vasospasm, and hypertension. In De Clerck and Vanhoutte (Eds) 5-Hydroxytryptamine in peripheral reactions, pp. 163–174, Raven Press, New York, 1982

    Google Scholar 

  • Vanhoutte PM. Peripheral serotonergic receptors and hypertension. In Vanhoutte PM (Ed.) Serotonin and the cardiovascular system, pp. 125–133, Raven Press, New York, 1985

    Google Scholar 

  • Vanhoutte PM, Shepherd JT. Effect of temperature on reactivity of saphenous, mesenteric, and femoral veins of the dog. American Journal of Physiology 218: 187–190, 1970

    PubMed  CAS  Google Scholar 

  • Vanhoutte PM, Van Nueten JM, Symoens J, Janssen, PAJ. Antihypertensive properties of ketanserin (R41468). Federation Proceedings 42: 182–185, 1983

    PubMed  CAS  Google Scholar 

  • Vanhoutte PM, Rimele TJ. Role of the endothelium in the control of vascular smooth muscle function. Journal of Physiology (Paris) 78: 681–686, 1983

    CAS  Google Scholar 

  • Van Nueten JM, Janssen PAJ, Van Bek J, Xhonneux R, Verbeuren TJ. et al. Vascular effects of ketanserin (R41468), a novel antagonist of 5-HT2 serotonergic receptors. Journal of Pharmacology and Experimental Therapeutics 218: 217–230, 1981

    PubMed  Google Scholar 

  • Van Nueten JM, Janssen PAJ, De Ridder W, Vanhoutte PM. Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R41468). European Journal of Pharmacology 77: 281–287, 1982

    PubMed  Google Scholar 

  • Van Nueten JM, Leysen JE, De Clerck F, Vanhoutte PM. Serotonergic receptor subtypes and vascular reactivity. Journal of Cardiovascular Pharmacology 6: S564–S574, 1984

    PubMed  Google Scholar 

  • Verheyen A, Vlaminckx E, Dauwers F, Van Den Broeck C, Wouters L. Serotonin-induced blood flow changes in the rat hind-legs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin. International Archives of Pharmacodynamics and Therapy 210: 280–294, 1984

    Google Scholar 

  • Voldby B, Engbaek F, Enevoldsen EM. CSF serotonin concentrations and cerebral arterial spasm in patients with ruptured intracranial aneurysm. Stroke 13: 184–189, 1982

    PubMed  CAS  Google Scholar 

  • Webb RC. Increased vascular sensitivity to serotonin and methysergide in hypertension in rats. Clinical Science 63: 73s, 1982

    Google Scholar 

  • Weiner CP, Socol ML, Vaisrub N. Control of preeclamptic hypertension by ketanserin — a serotonin receptor antagonist. American Journal of Obstetrics and Gynecology, 149: 496–500, 1984

    PubMed  CAS  Google Scholar 

  • Wenting GJ, Woittiez AJJ, Manin’t Veld AJ. Schalekamp MADH. 5-HT, alpha-adrenoceptors, and blood pressure: effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension 6: 100–109, 1984

    PubMed  CAS  Google Scholar 

  • Whigham KAE, Howie PW, Drummond AH, Prentice CRM. Abnormal platelet function in pre-eclampsia. British Journal of Obstetrics and Gynaecology 85: 28–32, 1978

    PubMed  CAS  Google Scholar 

  • White RP, Shirasawa Y, Robertson JT. Comparison of responses elicited by alpha-thrombin in isolated canine basilar, coronary, mesenteric, and renal arteries. Blood Vessels 21: 12–22, 1984

    PubMed  CAS  Google Scholar 

  • Winkelmann RK, Goldyne ME, Linscheid RL. Hypersensitivity of scleroderma cutaneous vascular smooth muscle to 5-hydroxytryptamine. British Journal of Dermatology 95: 51–56, 1976

    PubMed  CAS  Google Scholar 

  • Zervas NT, Candia M, Candia G, Kido D, Pessin MS, et al. Reduced incidence of cerebral ischemia following rupture of intracranial aneurysms. Surgical Neurology 11: 339–344, 1979

    PubMed  CAS  Google Scholar 

  • Zervas NT, Kuwayama A, Rosoff CB, Salzman EW. Cerebral arterial spasm: modification by inhibition of platelet function. Archives of Neurology 28: 400–404, 1973

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Houston, D.S., Vanhoutte, P.M. Serotonin and the Vascular System. Drugs 31, 149–163 (1986). https://doi.org/10.2165/00003495-198631020-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198631020-00004

Keywords

Navigation